Insulin regular (U-100)
Improve glycemic control in adult and pediatric patients with diabetes mellitus
High-alert medication
- Insulin, subcutaneous and IV (class)
Indications
- Improve glycemic control in adult and pediatric patients with diabetes mellitus
Adult dosing
- individualized: Consult pharmacy/current label
Pediatric dosing
- Consult pharmacy/current label
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Patients with hepatic impairment are at increased risk of hypoglycemia and may require more frequent dosage adjustment and monitoring.
Contraindications
- Hypoglycemia
- Hypersensitivity to HUMULIN R or any excipients
Clinical pearls
- Label provides no fixed starting dose; use institutional insulin protocol
- Confirm U-100 product; U-500 is a different product and is not interchangeable
- Inject SC 30 minutes before meals and rotate injection sites to prevent lipodystrophy.
- Monitor blood glucose and potassium levels closely during IV administration.
- Do not mix with other insulins except HUMULIN N; if mixing, draw HUMULIN R first and inject immediately.
- Patients with renal or hepatic impairment may require more frequent glucose monitoring due to increased hypoglycemia risk.
Source and review
- DailyMed label (insulin human, Humulin R), Set ID b519bd83-038c-4ec5-a231-a51ec5cc291f, effective 2026-06-16. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties